Results 1 to 10 of about 62,038 (305)

Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment‐resistant major depressive disorder

Neuropsychopharmacology Reports, 2020
Aim A substantial proportion of major depressive disorder patients are treatment‐resistant to antidepressant therapy, who require augmentation drugs, or other treatments including electroconvulsive therapy or transcranial magnetic stimulation ...
Katsuhiko Yamasaki, Tomonori Hasegawa, Masatoshi Takeda   +2 more
exaly   +3 more sources

Experimental Therapeutics in Treatment-Resistant Major Depressive Disorder

Journal of Experimental Pharmacology, 2021
Mandeep Kaur,1 Marsal Sanches2 1Department of Behavioral Medicine, Cone Health, Greensboro, NC, USA; 2UT Health Center of Excellence on Mood Disorders, Faillace Department of Psychiatry & Behavioral Sciences, McGovern Medical School, Houston, TX ...
Mandeep Kaur, Marsal Sanches
exaly   +6 more sources

Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone

Brain and Behavior, 2023
Background The impact of treatment‐resistant depression (TRD) or prior suicidal ideation/suicide attempt (SI/SA) on mortality by suicide among patients with major depressive disorder (MDD) is not well known. This retrospective, observational, descriptive
David M Kern, Carla M Canuso, Jonathan C Johnson   +2 more
exaly   +2 more sources

Case Report: rTMS for recurrent major depressive disorder and generalized anxiety disorder comorbid with atrial fibrillation [PDF]

Frontiers in Psychiatry
This paper examines the utilization of repetitive transcranial magnetic stimulation (rTMS) to treat recurrent Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) in a patient comorbid with atrial fibrillation (AF), a type of common ...
Vipul Reddy, Nadia Frutkin, Nadia Frutkin, Abeer Singh, Abeer Singh, Manya Pappu, Manya Pappu, Khimaya Raval, Khimaya Raval, Mark Odron, Charles Vigilia, Kenneth Blum, Kenneth Blum, Kenneth Blum, Kenneth Blum, Kenneth Blum, Kenneth Blum, David Baron, Keerthy Sunder, Keerthy Sunder, Keerthy Sunder, Keerthy Sunder   +21 more
doaj   +2 more sources

Treatment Resistant Bipolar Disorder [PDF]

Psikiyatride Güncel Yaklaşımlar, 2015
Many patients diagnosed with bipolar disorder respond incompletely or unsatisfactorily to available treatments. Defining refractoriness in bipolar disorder is a complex issue and should concern and include either every phase and pole or the disorder as a
Elvan Ozalp, Ersin Hatice Karslioglu
doaj   +2 more sources

Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report

Neuropsychiatric Disease and Treatment, 2013
Yuji Kitaichi,1 Takeshi Inoue,1 Nobuyuki Mitsui,1 Shin Nakagawa,1 Rie Kameyama,1 Yoshiyuki Hayashishita,1 Tohru Shiga,2 Ichiro Kusumi,1 Tsukasa Koyama1 1Department of Psychiatry, Graduate School of Medicine, Hokkaido University, Sapporo, Japan ...
Kitaichi Y, Inoue T, Mitsui N, Nakagawa S, Kameyama R, Hayashishita Y, Shiga T, Kusumi I, Koyama T   +8 more
doaj   +1 more source

A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients.

PLoS ONE, 2020
ObjectiveThe economic burden of commercially insured patients in the United States with treatment-resistant depression and patients with non-treatment-resistant major depressive disorder was compared using data from the Optum Clinformatics™ claims ...
Gang Li, Ling Zhang, Allitia DiBernardo, Grace Wang, John J Sheehan, Kwan Lee, Johan Reutfors, Qiaoyi Zhang   +7 more
doaj   +2 more sources

Comparison of cognitive function in patients with treatment-resistant depression and drug-naive first-episode major depressive disorder

Sichuan jingshen weisheng, 2021
ObjectiveTo explore the differences of cognitive function in patients with treatment-resistant depression and drug-naive first-episode major depressive disorder， and to examine the relationship between severity of clinical symptoms and cognitive function，
Zheng Chaodun, Chen Yingmei, Tan Jiuwei, Liu Guoxiong, Cai Yinglian, Lan Xiaofeng, Zhou Yanling   +6 more
doaj   +1 more source

Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' Group. [PDF]

PLoS ONE, 2016
'Treatment-resistant depression' is depression that does not respond to an adequate regimen of evidence-based treatment. Treatment-resistant depression frequently becomes chronic.
Tsuyoshi Sasaki, Kenji Hashimoto, Yasunori Oda, Tamaki Ishima, Madoka Yakita, Tsutomu Kurata, Masaru Kunou, Jumpei Takahashi, Yu Kamata, Atsushi Kimura, Tomihisa Niitsu, Hideki Komatsu, Tadashi Hasegawa, Akihiro Shiina, Tasuku Hashimoto, Nobuhisa Kanahara, Eiji Shimizu, Masaomi Iyo   +17 more
doaj   +1 more source

Resistance or pseudo-resistance?

European Psychiatry, 2022
Introduction Treatment-Resistant Depression continues to represent a great challenge for clinicians. Objectives We investigated patients with history of resistance, assessing prognostic factors, response to treatments, and remission over time ...
R. Zanardi, F. Attanasio, C. De Cesare, V. Fazio, C. Colombo   +4 more
doaj   +1 more source